(Q113889589)
Statements
A Multicenter, Randomized, Double-blind, Double-simulation, Active Comparator-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of X842 Capsules at Different Dosages in Patients With Reflux Esophagitis (English)
0 references
22 January 2019
0 references
31 October 2020
0 references
90
0 references
18 year
0 references
75 year
0 references